Callan Family Office’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-82,024
Closed -$64.8K 935
2025
Q1
$64.8K Buy
+82,024
New +$64.8K ﹤0.01% 538